HBAN
82
3
RCL
90
5
IVZ
55
2
AES
43
3
APA
45
6
PGR
49
2
BAC
63
3
FCX
62
6
EQIX
47
-7
PCG
53
2
ESS
36
6
CFG
90
6
VNO
49
4
ACN
45
3
DD
48
2
HCA
62
5
QCOM
62
2
TSN
46
3
MLM
38
3
CVS
60
-8
HBAN
82
3
RCL
90
5
IVZ
55
2
AES
43
3
APA
45
6
PGR
49
2
BAC
63
3
FCX
62
6
EQIX
47
-7
PCG
53
2
ESS
36
6
CFG
90
6
VNO
49
4
ACN
45
3
DD
48
2
HCA
62
5
QCOM
62
2
TSN
46
3
MLM
38
3
CVS
60
-8
Financhill
Back

SAB Biotherapeutics Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
25

SABS
SAB Biotherapeutics

Last Price:
$1.79
Seasonality Move:
-18.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow exec targets $1.3T marke

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

SAB Biotherapeutics Stock Forecast

  • Is SAB Biotherapeutics Stock Undervalued?
    The current SAB Biotherapeutics [SABS] share price is $1.78. The Score for SABS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • SABS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will SAB Biotherapeutics Stock Go Up Next Year?

Data Unavailable

SAB Biotherapeutics Stock Rating

Data Unavailable

SAB Biotherapeutics Stock Price History

Is SABS stock going to rise?

  • The current trend is relatively stagnant and SABS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sab.bio

52-Week Data

52-Week High:
5.01
52-Week Low:
1.00

Prediction Charts

Market Cap:
16.5M
Price in USD:
1.78
Volume:
9.1K
Beta:
0.55

Technical Analysis

SMA50:
1.74
SMA100:
1.68
SMA200:
2.46
52-Wk Change:
-37.1%

Stock Predictions

  • Is SAB Biotherapeutics stock public?
    Yes, SAB Biotherapeutics is a publicly traded company.
  • What is the SAB Biotherapeutics stock quote today?
    The SAB Biotherapeutics stock price is 1.78 USD today.
  • How to buy SAB Biotherapeutics stock online?
    You can buy SAB Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-6 1.92 1.81 1.92 1.80
Jun-9 1.87 1.86 1.88 1.79
Jun-10 1.85 1.87 1.89 1.79
Jun-11 1.84 1.88 1.88 1.82
Jun-12 1.86 1.83 1.89 1.73
Jun-13 1.85 1.71 1.85 1.60
Jun-16 1.74 1.70 1.77 1.65
Jun-17 1.70 1.78 1.79 1.65
Jun-18 1.80 1.78 1.80 1.67
Jun-20 1.78 1.79 1.79 1.72
Jun-23 1.82 1.76 1.82 1.72
Jun-24 1.80 1.80 1.80 1.72
Jun-25 1.79 1.82 1.85 1.73
Jun-26 1.87 1.78 1.87 1.77

SAB Biotherapeutics Earnings

Data Unavailable

SAB Biotherapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and a decrease next year of $0.65 per share.

* SAB Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.